Advances and Breakthroughs in Stem Cell Research
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Stem Cells".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 110
Special Issue Editors
Interests: investigating the mechanisms underlying the constitutive induced heteromerization of opioid receptors
Special Issues, Collections and Topics in MDPI journals
Interests: induced pluripotent stem cell-derived NK and T cells; hematopoietic stem cells; cancer immunotherapy; therapeutic antibody; host-pathogen interaction; immune dysfunction; off the shelf therapy; checkpoint inhibitors; metalloproteases; small molecule inhibitors; cardiovascular disorders; tuberculosis; sarcoidosis; allergy and asthma
Special Issue Information
Dear Colleagues,
This Special Issue will center around the latest cutting-edge breakthroughs in stem cell research within immunotherapy and regenerative medicine. In recent years, advancements in stem cell research have opened promising avenues for treating and potentially curing diverse conditions such as cancers, metabolic disorders, and neurodegenerative diseases. The immense potential of specific human iPSC-derived cell lineages, including CAR T cells, CAR NK cells, neurons, cardiomyocytes, and pancreatic islets, holds transformative possibilities in revolutionizing medical practices through the development of innovative therapies. This Special Issue will explore a range of topics related to stem cell therapy, encompassing iPSC (induced pluripotent stem cell)- or hematopoietic-stem-cell-derived, therapeutically relevant lineages. We welcome original manuscripts and reviews that delve into these subjects, contributing to a more profound comprehension of recent advancements and challenges in these domains.
Prof. Dr. Alexander E. Kalyuzhny
Dr. Hemant Kumar Mishra
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stem cell
- induced pluripotent stem cell
- iPSC
- hematopoietic stem cell
